Aspen Aerogels (NYSE: ASPN) stock surged over 7% in pre-market trading on Tuesday after the company reported impressive third-quarter 2024 financial results that exceeded expectations and raised its full-year guidance.
For the third quarter, Aspen Aerogels posted revenue of $117.3 million, up a staggering 93% year-over-year and beating the consensus estimate of $109.4 million. The company's net loss of $13 million, or $0.17 per share, was also better than the $0.08 loss per share expected by analysts.
Fueling the stock's rally was Aspen's increased optimism for 2024. The company now expects full-year revenue of $450 million, up from its previous forecast of greater than $390 million. Aspen also raised its 2024 earnings guidance, projecting net income of $9 million and adjusted EBITDA of $90 million, well above prior estimates.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。